London – A study conducted by researchers at Oxford University in England suggests that catchers are at higher risk in those experiencing dangerous, rare blood clots in the brain.Compared to those who either get the AstraZeneca vaccine, or in the US there are vaccines made by Pfizer and Moderna. Research shows that the number of people who experience clots after receiving vaccines made by American pharmaceutical giants is very similar. The rare condition, which was developed in conjunction with the Institute of Vaccine, Oxford, after a shot of the drug Ostrazeneca.
A major discovery of the research, on Thursday in the form of a “pre-print” study that is yet to be reviewed by other scientists, was that blood clotting experiences in the brain for people contracting COVID The risk was approximately 95 times higher. 19 as compared to the general population.
This is yet another serious health hazard associated with the disease, and one scientist hoped that all of the currently available major vaccines in the Western world would gain confidence, as their research suggests they risk clotting more than the disease Is quite low. ‘ve proved to be closed.
Analysis of real-world data collided by global health research network TriNetX and European agencies included information on hundreds of thousands of people who either caught COVID-19, or who were given, Pfizer or Modern Shots. Most data on mRNA-type vaccines, which are American drugs, were from the US, while data on AstraZeneca shots largely came from large-scale vaccination programs in Europe.
Data has shown that approximately 4 out of every 1 million people experience American-made vaccines cerebral venous thrombosis (CVT), or brain blood clots. With the AstraZeneca vaccine, which works in a different way and is similarResearch showed a rate of around 5 per 1 million.
This equates to a 10-fold higher risk of CVT for those who hold coronovirus than those who receive the Pfizer or Modern Vaccine, and 8 times higher for those given the AstraZeneca shot.
“There are concerns about possible associations between the vaccine and CVT, causing governments and regulators to restrict the use of certain vaccines,” said Paul Harrison, professor of psychiatry and head of Oxford’s translation neurology group. “We have reached two important conclusions. First, COVID-19 markedly increases the risk of CVT, making blood clotting problems one of the causes of this infection. Secondly, the current COVID-19 risk is even greater when viewed with a vaccine. For people under 30 years of age; there are some things to consider when considering the balance between the risks and benefits of vaccination. “
Research released on Thursday by Oxford found that out of every 1 million people who contract COVID-19, 39 are likely to experience brain clots. The scientists asserted that their research was not intended to compare vaccines, but rather to collect robust data on the risks of all vaccines compared to the risks associated with catching COVID-19.
“The indication that COVID-19 is associated with CVT, as well as portal vein thrombosis – a clotting disorder of the liver – is evident, and we should focus on one,” Dr. Maxim Taquet, another translational neurobiology group from researchers.
As the data used to determine the overall incidence rate were constantly being updated, the researchers insisted that “all comparisons should be interpreted carefully because the data are still accumulating.”
He also notes that it is still unclear whether “COVID-19 and the vaccine carry CVTs by the same or different mechanisms,” adding that this will be the subject of their ongoing research.